These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3308617

  • 1. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
    Ouzan D, Degos F, Marcellin P, Linberg J, Chevallier M, Degott C, Bréchot C, Chossegros P, Weiss AM, Hirtz J.
    Gastroenterol Clin Biol; 1987; 11(8-9):568-73. PubMed ID: 3308617
    [Abstract] [Full Text] [Related]

  • 2. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S, Thiers V, Boboc B, Housset C, Bréchot C, Degos F.
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [Abstract] [Full Text] [Related]

  • 3. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 4. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S, Saltiel C, Legendre C, Carnot F, Driss F, Berthelot P, Bréchot C, Ruet C, Kreis H.
    Nephrol Dial Transplant; 1994 May; 9(7):820-3. PubMed ID: 7526277
    [Abstract] [Full Text] [Related]

  • 6. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G, Santantonio T, Monno L, Milella M, Luchena N, Angarano G.
    Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M, Jardi R, Rodriguez-Frias F, Allende H, Cotrina M, Esteban R, Guardia J.
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
    Yao G, Wang B, Cui Z, Yao J, Zeng M.
    Chin Med J (Engl); 1999 May; 112(5):387-91. PubMed ID: 11593504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.